New hope for rare cancer: drug shows promise in shrinking adrenal tumors
NCT ID NCT03839498
First seen Mar 05, 2026 · Last updated May 10, 2026 · Updated 9 times
Summary
This study tests a daily pill called axitinib in adults with a rare type of adrenal tumor (pheochromocytoma or paraganglioma) that has spread or cannot be removed by surgery. The main goal is to see how many patients' tumors shrink or disappear. Researchers also track how long the disease stays under control. The study enrolled 6 participants and is no longer recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10031, United States
Conditions
Explore the condition pages connected to this study.